glp 1 mechanism of action incretin Frontiers Incretins role in metabolic homeostasis

PalmerSCMavridisDNicolucciAJohnsonDWTonelliMCraigJCet al

Regular bloodwork every three to six months helps monitor metabolic improvements and catch any unexpected changes early

This dynamic makes it simple to own NVO & LLY for the initial duopoly while owning smaller concentrations of the clinical stage companies for the option value once the duopoly is busted

Quick Answer: Aetna covers Ozempic and Mounjaro for type 2 diabetes with prior authorization on most commercial plans in 2026 A separate cardiovascular coverage pathway opened in 2024 after the SELECT trial (Lincoff et al

Nutrients (2019) 11(11):2566

Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity